These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36748708)

  • 1. Primary care physician use of patient race and polygenic risk scores in medical decision-making.
    Kerman BJ; Brunette CA; Harris EJ; Antwi AA; Lemke AA; Vassy JL
    Genet Med; 2023 Apr; 25(4):100800. PubMed ID: 36748708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Attitudes and Self-reported Practices Toward Prostate Cancer Screening in Black and White Men.
    Shungu N; Diaz VA; Perkins S; Kulshreshtha A
    Fam Med; 2022 Jan; 54(1):30-37. PubMed ID: 35006597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.
    Wilkes MS; Day FC; Srinivasan M; Griffin E; Tancredi DJ; Rainwater JA; Kravitz RL; Bell DS; Hoffman JR
    Ann Fam Med; 2013; 11(4):324-34. PubMed ID: 23835818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
    Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
    J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived benefits and barriers to implementing precision preventive care: Results of a national physician survey.
    Vassy JL; Kerman BJ; Harris EJ; Lemke AA; Clayman ML; Antwi AA; MacIsaac K; Yi T; Brunette CA
    Eur J Hum Genet; 2023 Nov; 31(11):1309-1316. PubMed ID: 36807341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care.
    Vassy JL; Brunette CA; Lebo MS; MacIsaac K; Yi T; Danowski ME; Alexander NVJ; Cardellino MP; Christensen KD; Gala M; Green RC; Harris E; Jones NE; Kerman BJ; Kraft P; Kulkarni P; Lewis ACF; Lubitz SA; Natarajan P; Antwi AA
    Am J Hum Genet; 2023 Nov; 110(11):1841-1852. PubMed ID: 37922883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision Making.
    Frego N; Beatrici E; Labban M; Stone BV; Filipas DK; Koelker M; Lughezzani G; Buffi NM; Osman NY; Lipsitz SR; Sammon JD; Kibel AS; Trinh QD; Cole AP
    Am J Prev Med; 2024 Jan; 66(1):27-36. PubMed ID: 37567369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussions about prostate cancer screening between U.S. primary care physicians and their patients.
    Hall IJ; Taylor YJ; Ross LE; Richardson LC; Richards TB; Rim SH
    J Gen Intern Med; 2011 Oct; 26(10):1098-104. PubMed ID: 21416405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.
    Feng B; Srinivasan M; Hoffman JR; Rainwater JA; Griffin E; Dragojevic M; Day FC; Wilkes MS
    Ann Fam Med; 2013; 11(4):315-23. PubMed ID: 23835817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions.
    Radhakrishnan A; Wallner LP; Skolarus TA; Abrahamse PH; Kollipara AS; Katz SJ; Hawley ST
    J Gen Intern Med; 2021 Feb; 36(2):447-454. PubMed ID: 33123958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study.
    Carlsson SV; Preston MA; Vickers A; Malhotra D; Ehdaie B; Healey MJ; Kibel AS
    Appl Clin Inform; 2024 Mar; 15(2):274-281. PubMed ID: 38599618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization.
    Lewis ACF; Perez EF; Prince AER; Flaxman HR; Gomez L; Brockman DG; Chandler PD; Kerman BJ; Lebo MS; Smoller JW; Weiss ST; Blout Zawatksy CL; Meigs JB; Green RC; Vassy JL; Karlson EW
    Genome Med; 2022 Oct; 14(1):114. PubMed ID: 36207733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.
    Aminsharifi A; Schulman A; Anderson J; Fish L; Oeffinger K; Shah K; Sze C; Tay KJ; Tsivian E; Polascik TJ
    Urol Oncol; 2018 Nov; 36(11):502.e1-502.e6. PubMed ID: 30170982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.